← Open Payments lookup

CAMRYN DAVIS: Open Payments

NPI 1518693746 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$706 in 42 payments from 12 companies in 2025. Trend: 2023 $116 · 2024 $259 · 2025 $706

Food & beverage: $706
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$136
Novo Nordisk Inc6$95
ABBVIE INC.4$85
Otsuka America Pharmaceutical, Inc.4$85
Xeris Pharmaceuticals, Inc.4$62
GlaxoSmithKline, LLC.3$52
Inspire Medical Systems, Inc.2$51
AstraZeneca Pharmaceuticals LP3$48
Exact Sciences Corporation2$30
Ascensia Diabetes Care Us Inc.1$22

Products named: CAPLYTA, REXULTI, VRAYLAR, TRELEGY ELLIPTA, INSPIRE, AIRSUPRA, RECORLEV, Wegovy.

Industry payments across MI — which companies pay providers there.